The inhaled administration of KF19514, a phosphodiesterase 4 and 1 inhibitor, prevents antigen-induced lung inflammation in guinea pigs

Pulmonary Pharmacology and Therapeutics

Volumn 13, Issue 1, 2000, Pages 5-11

  Manabe, H ^a   Akuta, K ^a   Kawasaki, H ^a   Ohmori, K ^a  

^a KYOWA HAKKO KOGYO CO LTD   (Japan)

Author keywords

Hyperresponsiveness; Inflammation; Inhalation; KF19514; Phosphodiesterase

Indexed keywords

ACETYLCHOLINE; AMINOPHYLLINE; BRONCHODILATING AGENT; KF 19514; OVALBUMIN; PHOSPHODIESTERASE INHIBITOR; ROLIPRAM; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ARTICLE; EOSINOPHIL; GUINEA PIG; LUNG COMPLIANCE; LUNG LAVAGE; LUNG RESISTANCE; MALE; NONHUMAN; PNEUMONIA; PRIORITY JOURNAL;

EID: 0034115537     PISSN: 10945539     EISSN: None     Source Type: Journal    
DOI: 10.1006/pupt.1999.0224     Document Type: Article

References (31)

1. National Asthma Education and Prevention Program, Guidelines for the Diagnosis and Management of Asthma. Expert Panel Report 2. National Institutes of Health, Bethesda, Maryland, USA, 1997.
2. Corrigan C. J., Kay A. T cell/eosinophil interactions in the induction of asthma. Eur Respir J. 9:1996;72S-78S.
3. Laitinen L. A., Laitinen A., Hahtela T. Airway muscle inflammation even in patients with newly diagnosed asthma. Am Rev Respir Dis. 147:1993;697-704.
4. Wills-Karp M. Smooth muscle as a direct or indirect target accounting for bronchopulmonary hyperresponsiveness. Res Immunol. 148:1997;59-72.
5. Beavo J. A., Reifsnyder D. H. Primary sequence of cyclic nucleotide phosphodiesterase isozymes and the design of selective inhibitors. Trends Pharmacol Sci. 11:1990;150-155.
6. Beavo J. A., Conti M., Heaslip R. J. Multiple cyclic nucleotide phosphodiesterases. Mol Pharmacol. 46:1994;399-405.
7. Nicholson C. D., Challiss R. A. J., Shahid M. Differential modulation of tissue function and therapeutic potential utility in the therapy of asthma. Trends Pharmacol Sci. 12:1991;19-27.
8. Heaslip R. J., Lombardo L. J., Galankiewics J. M., Ilsemann B. A., Evans D. Y., Sickels B. D., Mudrick J. K., Bagli J, Weichman B. M. Phosphodiesterase-IV inhibitor, respiratory muscle relaxation and bronchodilation by WAY-PDA-641. J Pharmacol Exp Ther. 268:1994;888-896.
9. Raeburn D., Underwood S. L., Lewis S. A., Woodman V. R., Battram C. H., Tomkinson A., RoyJordan S. S., Souness J. E., Webber S. E., Karlsson J. A. Anti-inflammatory and bronchodilator properties of RP 73401, a novel and selective phosphodiesterase type IV inhibitor. Br J Pharmacol. 113:1994;1423-1431.
10. Huges B., Howat D., Lisle M., Holbrook M., James T., Bozzard N., Blease K., Hughes P., Kingaby R., Warrellow G., Alexander R., Head J., Boyd E., Eaton M., Perry M., Wales M., Smith B., Owens R., Catterall C., Lumb S., Russell A., Allen R., Merriman M., Bloxham D., Higgs G. The inhibition of antigen-induced eosinophilia and bronchoconstriction by CDP 840, a novel stereoselective inhibitor of phosphodiesterase type 4. Br J Pharmacol. 118:1996;1183-1191.
11. Manabe H., Akuta K., Sejimo H., Kawasaki H., Nukui E., Ichimura M., Kase H., Kawakita T., Suzuki F., Kitamura S., Sato S., Ohmori K. Anti-inflammatory and bronchodilator properties of KF19514, a phosphodiesterase 4 and 1 inhibitor. Eur J Pharmacol. 332:1997;97-107.
12. Manabe H., Akuta K., Okamura K., Ohmori K. KF19514, a phosphodiesterase 4 and 1 inhibitor, inhibits PAF-induced lung inflammatory responses by inhaled administration in guinea pig. Int. Arch Allergy Immunol. 114:1997;398-399.
13. Fujimura M., Kita T., Myou S., Tachibana H., Matsuda T. Bronchoprotective effects of KF-19514 and cilostazol in guinea pigs in vivo. Eur. J. Pharmcol. 327:1997;57-63.
14. Virchow Jr J. C., Kroegel C., Matthys H. Antiasthma drug delivery. What is on the horizon? Clin Pharmacokinetics. 27:1994;85-93.
15. Boichot E., Lagente V., Came C., Waltmann P., Moncia-Huerta J. M., Braqet P. Bronchial hyperresponsiveness and cellular infiltration in the lung of guinea-pigs sensitized and challenged by aerosol. Clin Exp Allergy. 21:1991;67-76.
16. Barnes P. J. Cyclic nucleotides and phosphodiesterases and airway function. Eur Respir J. 8:1995;457-462.
17. Underwood D. C., Osborn R. R., Novak L. B., Matthews J. K., Newsholme S. J., Undem B. J., Hand J. M., Torphy T. J. Inhibition of antigen-induced bronchoconstriction and eosinophil infiltration in the guinea pig by the cyclic AMP-specific phosphodiesterase inhibitor, rolipram. J Pharmacol Exp Ther. 266:1993;306-313.
18. Turner C. R., Anderson C. J., Smith W. B., Watson J. W. Effects of rolipram on responses to acute and chronic antigen exposure in monkeys. Am J Respir Crit Care Med. 149:1994;1153-1159.
19. Santing R. E., Olymulder C. G., Van der Molen K., Meurs H., Zaagsma J. Phosphodiesterase inhibitors reduce bronchial hyperreactivity and airway inflammation in unrestrained guinea pigs. Eur J Pharmacol. 275:1995;75-82.
20. Lagente V., Pruniaux M. P., Junien J. L., Moodley I. Modulation of cytokine-induced eosinophil infiltration by phosphodiesterase inhibitors. Am J Respir Crit Care Med. 151:1995;1720-1724.
21. Lagente V., Boichot E., Carre C., Guinot P. H., Mencia-Huerta J. M., Braquet P. Effects of the platelet activating factor antagonists BN 52021 and BN 50730 on antigen-induced bronchial hyperresponsiveness and eosinophil infiltration in lung from sensitized guinea-pigs. Clin Exp Allergy. 23:1993;1002-1010.
22. Boichot E., Richard M. P., Paubert-Braquet M. Effect of Cefadroxil on antigen-induced brochial hyperresponsiveness and eosinophil accumulation in the lung from sensitized guinea pigs. Int Arch Allergy Immunol. 23:1993;87-93.
23. Santing R. E., Hoekstra Y., Pasman Y., Zaagsma J., Meurs H. The importance of eosinophil activation for the development of allergen-induced bronchial hyperreactivity in conscious, unrestrained guinea-pigs. Clin Exp Allergy. 24:1994;1157-1163.
24. Santing R. E., Olymulder C. G., Zaagsma J., Meurs H. Relationships among allergen-induced early and late phase airway obstractions, bronchial hyperreactivity, and inflammation in conscious, unrestrained guinea pigs. J Allergy Clin Immunol. 93:1994;1021-1030.
25. Santing R. E., Schraa E. O., Wachters A., Olymulder C. G., Zaagsma J., Meurs H. Role of histamine in allergen-induced asthmatic reactions, bronchial hyperreactivity and inflammation in unrestrained guinea pigs. Eur J Pharmacol. 254:1994;49-57.
26. Sato T., Iwama T., Shikada K., Tanaka S. Airway hyperresponsiveness to acetylcholine induced by aerosolized arachidonic acid metabolites in guinea-pigs. Clin Exp Allergy. 26:1996;957-963.
27. Manabe H., Ohnuma K., Ichimura M., Kawakita T., Suzuki F., Ohmori K. Pharmacological properties of a new bronchodilator, KF19514. Jpn J Pharmacol. 67:1995.
28. Gavett S. H., O'Hearn D. J., Karp C. L., Patel E. A., Schofield B. H., Finkelman F. D., Wills-Karp M. Interleukin-4 receptor blockade prevents airway responses induced by antigen challenge in mice. Am J Physiol. 272:1997;L253-L261.
29. Akutsu I., Kojima T., Kariyone A., Fukuda T., Makino S., Takatsu K. Antibody against interleukin-5 prevents antigen-induced eosinophil infiltration and bronchial hyperreactivity in the guinea pig airways. Immunol Lett. 45:1995;109-116.
30. Kips J. C., Tavernier J., Pauwels R. A. Tumor necrosis factor causes bronchial hyperresponsiveness in rats. Am Rev Respir Dis. 145:1992;332-336.
31. Banner K. H., Page C. P. Acute versus chronic administration of phosphodiesterase inhibitors on allergen-induced pulmonary cell influx in sensitized guinea-pigs. Br J Pharmacol. 114:1995;93-98.